A new highly specific monoclonal antibody against placental alkaline phosphatase: a potential marker for the early detection of testis tumour - PubMed
A M Nouri 1 , N Torabi-Pour, A A Dabare
Article Images
A new highly specific monoclonal antibody against placental alkaline phosphatase: a potential marker for the early detection of testis tumour
A M Nouri et al. BJU Int. 2000 Nov.
Abstract
Objective: To develop specific monoclonal antibodies (mAbs) against human germ cell tumours.
Materials and methods: A single-cell suspension obtained from tumour tissue fragments (consisting of both tumour and normal compartments) from a patient with seminoma was used as an immunogen. Spleen cells from immunized mice were used to develop mAbs. Tissue specificity, biochemical characteristics and competitive studies were analysed using immunocytochemical staining, dot blots and a Western blot analysis, to identify target antigen(s).
Results: The immunization protocol led to the development of 107 hybridomas, 90 of which were negative against the original tissue biopsies. The remaining 17 showed positivity against various tissue compartments. One selected mAb (ATC2) showed specific staining on germ cell tumours but not on normal tissues, and positive staining with some human tumour cell lines. The target antigen for ATC2 was confirmed to be placental alkaline phosphatase (PLAP) based on: Western blot analysis compared with commercially available PLAP; comparison of the data with another well-known anti-PLAP mAb (H17E2, although the two mAbs recognized different antigenic epitopes); heat resistance characteristics; high-performance liquid chromatography of the ATC2 target antigen and purified PLAP.
Conclusion: The selected mAb ATC2 has high specificity for human germ cell tumours, the target antigen for ATC2 being PLAP, although the antigenic epitope(s) differ from those recognized by H17E2. Thus ATC2 may be useful for monitoring serum levels of PLAP in patients with testis cancer and may be relevant for detecting cancer cells in the semen of individuals with suspected testis cancer, particularly in those with equivocal findings on ultrasonography.
Similar articles
-
Koshida K, Uchibayashi T, Yamamoto H, Yokoyama K, Hirano K. Koshida K, et al. J Urol. 1996 Jan;155(1):337-41. J Urol. 1996. PMID: 7490882
-
Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, von Keitz A, Looijenga LH, Millán JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebaek NE, van Putten W, Stern P. Andrews PW, et al. Int J Cancer. 1996 Jun 11;66(6):806-16. doi: 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8647654
-
Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E, Nielsen JE, Skakkebaek NE, Almstrup K. Rajpert-De Meyts E, et al. Folia Histochem Cytobiol. 2015;53(3):177-88. doi: 10.5603/FHC.a2015.0020. Epub 2015 Aug 26. Folia Histochem Cytobiol. 2015. PMID: 26306513 Review.
-
Clinical and biological significance of an isozyme tumor marker--PLAP.
Fishman WH. Fishman WH. Clin Biochem. 1987 Dec;20(6):387-92. doi: 10.1016/0009-9120(87)90003-8. Clin Biochem. 1987. PMID: 3325192 Review.
Cited by
-
Induced Pluripotent Stem Cell-Based Cancer Vaccines.
Ouyang X, Telli ML, Wu JC. Ouyang X, et al. Front Immunol. 2019 Jul 8;10:1510. doi: 10.3389/fimmu.2019.01510. eCollection 2019. Front Immunol. 2019. PMID: 31338094 Free PMC article. Review.
-
Specific immunoassays for placental alkaline phosphatase as a tumor marker.
Stinghen ST, Moura JF, Zancanella P, Rodrigues GA, Pianovski MA, Lalli E, Arnold DL, Minozzo JC, Callefe LG, Ribeiro RC, Figueiredo BC. Stinghen ST, et al. J Biomed Biotechnol. 2006;2006(5):56087. doi: 10.1155/JBB/2006/56087. J Biomed Biotechnol. 2006. PMID: 17489017 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical